94 research outputs found

    Assessing and managing hallucinations in children and adolescents

    Get PDF
    Children and young people who disclose sensory experiences suggestive of hallucinations do pose a diagnostic and therapeutic challenge to mental health clinicians in their daily practice. Hallucinations, defined as erroneous percepts in the absence of identifiable stimuli, are a key feature of psychotic states, but they had also long been known to present in children with non-psychotic psychiatric disorders. The recent upsurge of interest in childhood hallucinations has arisen out of epidemiological studies of child populations, where comprehensive symptom enquiry has included screening questions on abnormal perceptions. This has resulted in what seemed surprisingly high rates of hallucinatory experiences among other psychotic-like symptoms. Children and ado lescents show a prevalence rate of self-reported hallucinatory experiences of about 10% and are reported as more common in childhood than in adolescence. These hallucinatory phenomena are most likely to occur in the absence of any psychiatric disorder and would be expected more often than not to be simpler, less elaborate and distressing than those observed in clinical samples of children with psychiatric disorders. Longitudinal studies have in fact shown that only a small proportion of children in the general population with hallucinations (less than 10%) will suffer from a psychotic disorder later in life. In clinical settings, presentations with hallucinations can be an expression of a psychotic state, or alternatively of a symptom constellation co-occurr ing along other psychiatric conditions. Associations have been found between hallucinations and traumatic stressors (i.e. bullying and sexual assault), severity of psychopathology and suicidal symptoms. These associations could be mediated by individual vulnerability, involving neurodevelopmental anomalies and a tendency to mental dissociation and mood dysregulation. This review details the clinical assessment of hallucinations in children and adolescents taking into account developmental considerations and paediatric organic associations. It describes hallucinations in young people with psychoses (schizophrenic spectrum and mood disorders) and other non-psychotic psychiatric disorders (emotional and behavioural disorders), and it addresses therapeutic aspects

    Implementation of routine outcome measurement in child and adolescent mental health services in the United Kingdom: a critical perspective

    Get PDF
    The aim of this commentary is to provide an overview of clinical outcome measures that are currently recommended for use in UK Child and Adolescent Mental Health Services (CAMHS), focusing on measures that are applicable across a wide range of conditions with established validity and reliability, or innovative in their design. We also provide an overview of the barriers and drivers to the use of Routine Outcome Measurement (ROM) in clinical practice

    Emotional impact of genetic trials in progressive paediatric disorders: a dose-ranging exon-skipping trial in Duchenne muscular dystrophy.

    Get PDF
    Gene-modifying trials offer hope for improvement in chronic paediatric disorders, but they may also lead to disappointment and have an adverse emotional effect on families. This study aimed to examine emotional impact on participants in a paediatric exon-skipping trial

    Evaluation of sleep, puberty and mental health in children with long-term melatonin treatment for chronic idiopathic childhood sleep onset insomnia

    Get PDF
    OBJECTIVES: To establish whether long-term use of melatonin influences pubertal development, sleep quality and mental health development in children as compared with the normal Dutch population of the same age. METHODS: This follow-up research study was conducted in children included in a previous melatonin dose-finding trial. Outcomes were measured using questionnaires (Strength and Difficulties Questionnaire (SDQ), Children's Sleep Habits Questionnaire (CSHQ) and Tanner Stages) adopted for Dutch children. Mean duration of therapy, persistence of effect, adverse events and (other) reasons leading to cessation of therapy were additional objectives of this study. RESULTS: Mean years of usage (n = 51) was 3.1 years (min 1.0 year, max 4.6 years), mean dose 2.69 mg (min 0.3 mg, max 10 mg). Mean SDQ score, mean CSHQ score and Tanner Stages standard deviation scores did not differ in a statistically significant way from published scores of the general Dutch population of the same age and sex. CONCLUSIONS: This follow-up study demonstrates that melatonin treatment in children can be sustained over a long period of time without substantial deviation of the development of children with respect to sleep quality, puberty development and mental health scores, as compared with the general Dutch population

    Agreement on Web-based Diagnoses and Severity of Mental Health Problems in Norwegian Child and Adolescent Mental Health Services

    Get PDF
    Objective: This study examined the agreement between diagnoses and severity ratings assigned by clinicians using a structured web-based interview within a child and adolescent mental health outpatient setting. Method: Information on 100 youths was obtained from multiple informants through a web-based Development and Well-Being Assessment (DAWBA). Based on this information, four experienced clinicians independently diagnosed (according to the International Classification of Diseases Revision 10) and rated the severity of mental health problems according to the Health of the Nation Outcome Scales for Children and Adolescents (HoNOSCA) and the Children’s Global Assessment Scale (C-GAS). Results: Agreement for diagnosis was κ=0.69-0.82. Intra-class correlation for single measures was 0.78 for HoNOSCA and 0.74 for C-GAS, and 0.93 and 0.92, respectively for average measures. Conclusions: Agreement was good to excellent for all diagnostic categories. Agreement for severity was moderate, but improved to substantial when the average of the ratings given by all clinicians was considered. Therefore, we conclude that experienced clinicians can assign reliable diagnoses and assess severity based on DAWBA data collected online

    Kidney transplantation in childhood: mental health and quality of life of children and caregivers

    Get PDF
    Our objective was to assess the mental health and health-related quality of life (HRQOL) in children and their parents after renal transplantation (TX) compared to healthy controls and children with acute lymphoblastic leukemia (ALL) and to identify possible health status variables associated with impaired mental health and HRQOL. Thirty-eight TX children with a median age of 13 (range 3–19) years were investigated. Mental health was assessed by the Pediatric Quality of Life Inventory (PedsQL) 4.0 Generic Core Scales and the Strength and Difficulties Questionnaire (SDQ-20). Each mother’s own mental health and QOL were assessed by the General Health Questionnaire (GHQ-30) and the Quality of Life Scale (QOLS). Forty children with ALL [median age 11 (8.5–15.4) years] and 42 healthy children [median age 11 (8.9– 15) years] served as controls. Treadmill exercise results from 22 of the 38 patients were included in the analysis. TX children showed significantly higher levels of mental health problems and lower HRQOL at 2 to 16 years after transplantation compared to both control groups. Body mass index and maximal oxygen uptake (n = 22/38) were significant predictors of child mental health (SDQ) and child QOL (PedsQL), respectively. Based on these results, we suggest that rehabilitation after TX should include a focus on physical activity and QOL to reduce interconnected physical and psychological morbidity in kidney TX children
    • …
    corecore